Review of fecal biomarkers in inflammatory bowel disease

被引:95
作者
Sutherland, Andrew D.
Gearry, Richard B. [2 ]
Frizelle, Frank A. [1 ]
机构
[1] Christchurch Hosp, Dept Surg, Colorectal Unit, Christchurch, New Zealand
[2] Christchurch Hosp, Dept Gastroenterol, Christchurch, New Zealand
关键词
ulcerative colitis; Crohn's disease; inflammatory bowel disease; biomarkers; calprotectin; lactoferrin;
D O I
10.1007/s10350-008-9310-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We reviewed potential fecal biomarkers of inflammatory bowel disease and assessed their utility in a range of clinical applications. A literature search using PubMed, MEDLINE, and Embase database was performed, locating all language articles on fecal biomarkers, including calprotectin and lactoferrin. The references of these papers were searched manually for further references. A wide range of fecal biomarkers have been evaluated in the research setting. Only fecal calprotectin and lactoferrin have translated into useful clinical tools. These biomarkers have demonstrated high sensitivity for organic intestinal disease and good correlation with other measures of disease activity in inflammatory bowel disease. Fecal calprotectin and lactoferrin are useful triage tools to differentiate organic intestinal disorders from functional disorders. They also have a role in monitoring inflammatory bowel disease activity and predicting relapse.
引用
收藏
页码:1283 / 1291
页数:9
相关论文
共 56 条
[1]   FECAL ELASTASE REFLECTS DISEASE-ACTIVITY IN ACTIVE ULCERATIVE-COLITIS [J].
ADEYEMI, EO ;
HODGSON, HJF .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (02) :139-142
[2]   Enzymes in feces: Useful markers of chronic inflammatory bowel disease [J].
Angriman, Imerio ;
Scarpa, Marco ;
D'Inca, Renata ;
Basso, Daniela ;
Ruffolo, Cesare ;
Polese, Lino ;
Sturniolo, Giacomo C. ;
D'Amico, Davide F. ;
Plebani, Mario .
CLINICA CHIMICA ACTA, 2007, 381 (01) :63-68
[3]   DIAGNOSIS OF PROTEIN-LOSING ENTEROPATHY BY GASTROINTESTINAL CLEARANCE OF ALPHA-1-ANTITRYPSIN [J].
BERNIER, JJ ;
FLORENT, C ;
DESMAZURES, C ;
AYMES, C ;
LHIRONDEL, C .
LANCET, 1978, 2 (8093) :763-764
[4]   Fecal α1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum [J].
Biancone, L ;
Fantini, M ;
Tosti, C ;
Bozzi, R ;
Vavassori, P ;
Pallone, F .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (03) :261-266
[5]   Faecal calprotectin in children with chronic gastrointestinal symptoms [J].
Bremner, A ;
Roked, S ;
Robinson, R ;
Phillips, I ;
Beattie, M .
ACTA PAEDIATRICA, 2005, 94 (12) :1855-1858
[6]   Fecal lactoferrin: A new parameter to monitor infliximab therapy [J].
Buderus, S ;
Boone, J ;
Lyerly, D ;
Lentze, MJ .
DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (06) :1036-1039
[7]   Combined use of Noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease [J].
Canani, RB ;
de Horatio, LT ;
Terrin, G ;
Romano, MT ;
Miele, E ;
Staiano, A ;
Rapacciuolo, L ;
Polito, G ;
Bisesti, T ;
Manguso, F ;
Vallone, G ;
Sodano, A ;
Troncone, R .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2006, 42 (01) :9-15
[8]   Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: A prospective study in adults and children [J].
Carroccio, A ;
Iacono, G ;
Cottone, M ;
Di Prima, L ;
Cartabellotta, F ;
Cavataio, F ;
Scalici, C ;
Montalto, G ;
Di Fede, G ;
Rini, G ;
Notarbartolo, A ;
Averna, MR .
CLINICAL CHEMISTRY, 2003, 49 (06) :861-867
[9]   GUT LAVAGE FLUID PROTEIN CONCENTRATIONS - OBJECTIVE MEASURES OF DISEASE-ACTIVITY IN INFLAMMATORY BOWEL-DISEASE [J].
CHOUDARI, CP ;
OMAHONY, S ;
BRYDON, G ;
MWANTEMBE, O ;
FERGUSON, A .
GASTROENTEROLOGY, 1993, 104 (04) :1064-1071
[10]   Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease [J].
Costa, F ;
Mumolo, MG ;
Ceccarelli, L ;
Bellini, M ;
Romano, MR ;
Sterpi, C ;
Ricchiuti, A ;
Marchi, S ;
Bottai, M .
GUT, 2005, 54 (03) :364-368